GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Oxford University Press (OUP) ; 2019
    In:  Open Forum Infectious Diseases Vol. 6, No. Supplement_2 ( 2019-10-23), p. S151-S152
    In: Open Forum Infectious Diseases, Oxford University Press (OUP), Vol. 6, No. Supplement_2 ( 2019-10-23), p. S151-S152
    Abstract: Histoplasmosis is a systemic mycosis with a wide range of clinical manifestations which represents a diagnostic challenge. It affects immunocompromised patients but also, previously healthy individuals that are exposed to a large inoculum of Histoplasma. The aim of our study was to describe the clinical presentation, epidemiologic features, laboratory/imaging findings and outcome of pediatric patients with histoplasmosis. Methods a retrospective study including patients diagnosed as Histoplasmosis according to ICD-10 at a tertiary care center in Mexico City during 2009 to 2019. Clinical, epidemiological and laboratory/imaging data were gathered from each patient’s clinical file. Results 5 patients with diagnosis of histoplasmosis were included; 2 patients were classified as proven with histopathologic confirmation, 2 patients as probable and 1 patient as possible according to the EORTC/MSG. The mean age of presentation was 7 years, 3/5 patients were male and 3/5 reported exposure to bats. Diagnosis was delayed by an average time of 6 months due to the variability of clinical presentations (progressive disseminated histoplasmosis, spinal histoplasmosis, cerebral histoplasmosis, intestinal histoplasmosis and mild acute pulmonary histoplasmosis). For the diagnosis, 1/5 had positive ELISA, 1/5 positive immunodiffusion (M band), 1/5 positive EIA in cerebrospinal fluid and 2/5 with histopathology findings that matched histoplasmosis. Pulmonary imaging with interstitial infiltrates in 4/5 and evidence of cavitation in one patient. Hemophagocytic syndrome was a complication in 1/5 and medullary syndrome was developed in the patient with spinal histoplasmosis which resolved with treatment. Liposomal amphotericin B was the treatment in 4/5, followed by itraconazole as the maintenance therapy. Conclusion This study shows variable clinical presentations of Histoplasmosis which resulted in an important delay in diagnosis. This study highlights the importance of diagnostic suspicion in both healthy children and immunocompromised patients, always taking into account epidemiological risks such as exposure to bats. Disclosures All authors: No reported disclosures.
    Type of Medium: Online Resource
    ISSN: 2328-8957
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2019
    detail.hit.zdb_id: 2757767-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...